A comprehensive view of Cysts / Lesions / Tumors. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Bristol-Myers Squibb on April 30 for "Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors" (American, Indian Inventors)

'Anti-Ror1 Macrocyclic Peptides And Compositions' in Patent Application Approval Process (USPTO 20240116988)

Patent Issued for Bispecific antibodies against CD3EPSILON and ROR1 (USPTO 11952421)

FDA approves Novartis' Lutathera for treatment of certain pediatric gastroenteropancreatic neuroendocrine tumors; Lutathera is the first therapy specifically approved for such pediatric patients

Patent Issued for Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression (USPTO 11952574)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count